Marja van Meijer
- Molecular Biology
- Hematology top 5%
- Genetics top 10%
- Cancer Research top 10%
- Oncology
- Co-authors
- Hans PannekoekAnton Jan van ZonneveldJohn de KruifJaap GoudsmitMenzo HavengaOlga OphorstKlaus T. PreissnerAnton J.G. Horrevoets
- Topics
- Protease and Inhibitor Mechanisms (8 papers)Blood Coagulation and Thrombosis Mechanisms (6 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)
- Partner nations
- NetherlandsCanadaUnited States
In The Last Decade
Marja van Meijer
17 papers receiving 882 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 453
- Hematology 290
- Genetics 232
- Cancer Research 224
- Oncology 223
Countries citing papers authored by Marja van Meijer
This map shows the geographic impact of Marja van Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja van Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja van Meijer more than expected).
Fields of papers citing papers by Marja van Meijer
This network shows the impact of papers produced by Marja van Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja van Meijer. The network helps show where Marja van Meijer may publish in the future.
Co-authorship network of co-authors of Marja van Meijer
This figure shows the co-authorship network connecting the top 25 collaborators of Marja van Meijer. A scholar is included among the top collaborators of Marja van Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja van Meijer. Marja van Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 63 | |
| 5 | 196 | |
| 6 | 155 | |
| 7 | 79 | |
| 8 | 17 | |
| 9 | 3 | |
| 10 | 21 | |
| 11 | 49 | |
| 12 | 31 | |
| 13 | 47 | |
| 14 | 40 | |
| 15 | 2 | |
| 16 | 121 | |
| 17 | 44 | |
| 18 | 39 |
About Marja van Meijer
Marja van Meijer is a scholar working on Hematology, Cancer Research and Immunology and Allergy, having authored 18 papers that have together received 919 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Hematology (290 citations), Cancer Research (224 citations) and Immunology and Allergy (79 citations). Marja van Meijer has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Hans Pannekoek, Anton Jan van Zonneveld, John de Kruif, Jaap Goudsmit, Menzo Havenga, Olga Ophorst, Klaus T. Preissner, Anton J.G. Horrevoets, Mark Throsby and Wilfred E. Marissen. Their work appears in journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.